- A Comprehensive Preclinical Study: Molecular Therapy: Original Article. Methods & Clinical Development Vol. 24 March 2022. A comprehensive preclinical study supporting clinical trial of oncolytic chimeric poxvirus CF33-hNIS-anti-PD-L1 to treat breast cancer. Published: 2022
- Successful IND Preclinical Toxicology Study: CBI conducted the preclinical toxicology studies that enabled the successful IND with this important new drug in development. A comprehensive preclinical study supporting clinical trial of oncolytic chimeric poxvirus CF33-hNIS-anti-PD-L1 to treat breast cancer. Published: 2022
- Preclinical Animal Models of COVID-ARD: CBI is offering customized preclinical animal models to address acute respiratory failure in COVID-19 pulmonary infections. CBI-White Papers-Preclinical Animal Models of COVID-ARDS Published: 2020
- Poster Study: A pilot study of antimicrobial photodynamic therapy of encapsulated Aspergillus fumigatus in a rabbit maxillary sinus model. : CBI-In Vivo Efficacy Study Showing Antimicrobial Photodynamic Therapy of Encapsulated Aspergillus Fumigatus in a Rabbit Sinus Model Published: 2020
- Carol Meschter of CBI gets article published and is now available to view in Cureus. : CBI-In Vivo Efficacy Study Showing Comparative Advantage of Bacterial Infection Prevention with Zip-type Skin Closure Device vs. Subcuticular Sutures Published: August 04, 2018
- White Paper for Validation Study: CBI-White Papers- Delayed Type Hypersensitivity- Ear Thickness Model in Mice. 2018. J. Christensen • Robert Sukhu • Qin Zhang • Isaac Hakim • Carol Meschter
- White Paper for Validation Study: CBI-White Papers- Melanin Associated Antigen-Induced Anterior Uveitis in Lewis Rats. 2017. Robin Dean • Robert Sukhu • Leslie Nemeth • Qin Zhang • Isaac Hakim Ali Ebramhimnejad • Carol Meschter
- White Paper for Validation Study: CBI-White Papers- Streptozotocin-Induced Diabetes as a Model of Diabetic Retinopathy in Brown Norway Rats. 2017. Robin Dean • Robert Sukhu • Leslie Nemeth • Carol Meschter
- White Paper for Validation Study: CBI-White Papers- Postnatal Hyperoxia-Induced Lung Injury in Infant Rats. 2017. Alireza Ebrahimnejad • Felisha Paniagua • Robert Sukhu • Carol Meschter
-
White Paper for Validation Study: CBI-White Papers:Four New Models of Pulmonary Infection. 2017. Hong Du • Robert Sukhu • Carol Meschter
- Poster presented at: Society of Toxicology Annual Meeting; March 12-15, 2017; Quantification of lung injury with phase contrast analysis in a rodent model of postnatal hyperoxia-induced pulmonary dysplasia. Baltimore, MD. Ooi L, Zhang Q, Ebrahimnejad A, Paniagua F, Sukhu R, Meschter C, Warren D.
- Foubert P., Barillas S., Gonzalez A.D., Alfonso Z., Zhao S., Hakim I., Meschter C., Tenenhaus M., Fraser J.K.: Uncultured adipose-derived regenerative cells (ADRCs) seeded in collagen scaffold improves dermal regeneration, enhancing early vascularization and structural organization following thermal burns. Burns. 2015 Nov;41(7). Epub 2015 Jun 6.
- KooE, OshodiT, MeschterC, Ebrahimnejad A, Dong G: Neurotoxic effects of dexmedetomidine in fetal cynomolgus monkey brains. Accepted, Dec2013 Journal of Toxicological Sciences, Accepted for Publication, Dec 2013
- Billetta R, Ghahramani N, Morrow O, Prakken B, de Jong H, Meschter C, Lanza P, Albani S. Epitope-specific immune tolerization ameliorates experimental autoimmune encephalomyelitis. Clin Immunol. 2012 Nov;145(2).
- Noh MJ, Copeland RO, Yi Y, Choi KB, Meschter C, Hwang S, Lim CL, Yip V, Hyun JP, Lee HY, Lee KH. Pre-clinical studies of retrovirally transduced human chondrocytes expressing transforming growth factor-beta-1 (TG-C). Cytotherapy. 2010 May;12(3):384-93.
- Inhibition of mast cell function limits choroidal neovascularization in rat laser induced macular degeneration models. Katarzyna A. Trzaska-Accurso1, Carol Meschter C, Sweeney C, Burtis B, Ling-Min L, Pincus MJ, Jupp R, Hahn CS. Accepted, Nature
- Alban S, Meschter C, et al; entitled “A Trigger-Agnostic Epitope-Specific Immunotherapy Ameliorates Experimental Autoimmune Encephalomyelitis (EAE),” Submitted to J Immunol, Jun2011. Accepted, 2012
- Suprachoroidal Microinjection Delivers Triamcinolone Acetonide to Therapeutically-Relevant Ocular Structures of Posterior Segment Disease and Limits Exposure in the Anterior Segment. Edelhauser H, Patel S, Meschter C, Dean R, Powell K, Verhoeven R. ARVO Poster Presentation 2013 Annual Meeting, May 5-9, 2013 Seattle WA.
- Evaluation of Suprachoroidal Microinjection of Triamcinolone Acetonide in a Model of Posterior Uveitis in Albino Rabbits. Patel S, Carvalho R, Mundwiler K, Meschter C, Verhoeven R. ARVO Poster Presentation 2013 Annual Meeting, May 5 – 9, 2013 Seattle WA.